Abstract
Cardiac dysfunction is a common complication in sepsis and is characterized by forward pump failure. Hallmarks of septic cardiomyopathy are decreased myofibrillar contractility and reduced Ca2+ sensitivity but it is still not clear whether reduced pump efficiency is predominantly a diastolic impairment. Moreover, a comprehensive picture of upstream Ca2+ handling mechanisms and downstream myosin biomechanical parameters is still missing. Ca2+-sensitizing agents in sepsis may be promising but mechanistic insights for drugs like levosimendan are scarce. Here, we used an endotoxemic LPS rat model to study mechanisms of sepsis on in vivo hemodynamics, multicellular myofibrillar Ca2+ sensitivity, in vitro cellular Ca2+ homeostasis and subcellular actomyosin interaction with intracardiac catheters, force transducers, confocal Fluo-4 Ca2+ recordings in paced cardiomyocytes, and in vitro motility assay, respectively. Left ventricular ejection fraction and myofibrillar Ca2+ sensitivity were depressed in LPS animals but restored by levosimendan. Diastolic Ca2+ transient kinetics was slowed down by LPS but ameliorated by levosimendan. Selectively blocking intracellular and sarcolemmal Ca2+ extrusion pathways revealed minor contribution of sarcoplasmic reticulum Ca2+ ATPase (SERCA) to Ca2+ transient diastole in LPS-evoked sepsis but rather depressed Na+/Ca2+ exchanger and plasmalemmal Ca2+ ATPase. This was mostly compensated by levosimendan. Actin sliding velocities were depressed in myosin heart extracts from LPS rats. We conclude that endotoxemia specifically impairs sarcolemmal diastolic Ca2+ extrusion pathways resulting in intracellular diastolic Ca2+ overload. Levosimendan, apart from stabilizing Ca2+-troponin C complexes, potently improves cellular Ca2+ extrusion in the septic heart.
Similar content being viewed by others
References
Aoki Y, Hatakeyama N, Yamamoto S, Kinoshita H, Matsuda N, Hattori Y, Yamazaki M (2012) Role of ion channels in sepsis-induced atrial tachyarrhythmias in guinea pigs. Br J Pharmacol 166(1):390–400. doi:10.1111/j.1476-5381.2011.01769.x
Bruni FD, Komwatana P, Soulsby ME, Hess ML (1978) Endotoxin and myocardial failure: role of the myofibril and venous return. Am J Physiol 235(2):H150–H156
Celes MR, Malvestio LM, Suadicani SO, Prado CM, Figueiredo MJ, Campos EC, Freitas AC, Spray DC, Tanowitz HB, da Silva JS, Rossi MA (2013) Disruption of calcium homeostasis in cardiomyocytes underlies cardiac structural and functional changes in severe sepsis. PLoS One 8(7):e66809. doi:10.1371/journal.pone.0068809
Ceylan-Isik AF, Zhao P, Zhang B, Xiao X, Su G, Ren J (2010) Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis. J Mol Cell Cardiol 48(2):367–378. doi:10.1016/j.yjmcc.2009.11.003
Duncan DJ, Yang Z, Hopkins PM, Steele DS, Harrison SM (2010) TNF-alpha and IL-1beta increase Ca2 + leak from the sarcoplasmic reticulum and susceptibility arrhythmia in rat ventricular myocytes. Cell Calcium 47(4):378–386. doi:10.1016/j.ceca.2010.02.002
Edes I, Kiss E, Kitada Y, Powers FM, Papp JG, Kranias EG, Solaro RJ (1995) Effects of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2 + sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 77(1):107–113. doi:10.1161/01.RES.77.1.107
Endoh M (2008) Cardiac Ca2+ signaling and Ca2+ sensitizers. Circ J 72:1915–1925. doi:10.1253/circj.CJ-08-0838
Flynn A, Chokkalingam MB, Mather PJ (2010) Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms. Heart Fail Rev 15(6):605–611. doi:10.1007/s10741-010-9176-4
Gandhi A, Siedlecka U, Shah AP, Navratnarajah M, Yacoub MH, Terracciano CM (2013) The effect of SN-6, a novel sodium––calcium exchange inhibitor, on contractility and calcium handling in isolated failing rat ventricular myocytes. Cardiovasc Ther 31(6):e115–e124. doi:10.1111/1755-5922.12045
Gödeny I, Pollesello P, Edes I, Papp Z, Bagi Z (2013) Levosimendan and its metabolite OR-1896 elicit KATP channel-dependent dilation in resistance arteries in vivo. Pharmacol Rep 65(5):1304–1310. doi:10.1016/S1734-1140(13)71488-9
Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Linden IB (1995) Troponin C-mediated calcium-sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 25(5):794–801. doi:10.1097/00005344-199505000-00016
Hassoun SM, Marechal X, Montaigne D, Bouazza Y, Decoster B, Lancel S, Neviere R (2008) Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction. Crit Care Med 36(9):2590–2596. doi:10.1186/cc4854
Heinzel FR, Gres P, Boengler K, Duschin A, Konietzka I, Rassaf T, Snedovskaya J, Meyer S, Skyschally A, Kelm M, Heusch G, Schulz R (2008) Inducible nitric oxide expression and cardiomyocyte dysfunction during sustained moderate ischemia in pigs. Circ Res 103:1120–1127. doi:10.1161/CIRCRESAHA.108.186015
Hillestad V, Kramer F, Golz S, Knorr A, Andersson KB (1985) Christensen G (1985) Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene. J Appl Physiol 115(10):1572–1580. doi:10.1152/japplphysiol.01044.2012
Hobai IA, Buys ES, Morse JC, Edgecomb J, Weiss EH, Amoundas AA, Hou X, Khandelwal AR, Siwik DA, Brouckaert P, Cohen RA, Colucci WS (2013) Cys674 sulphonylation and inhibition of L-type Ca2 + influx contribute to cardiac dysfunction in endotoxemic mice, independent of cGMP synthesis. Am J Physiol Heart Circ Physiol 305(8):H1189–H1200. doi:10.1152/ajpheart.00392.2012
Koesters A, Engisch KL, Rich MM (2014) Decreased cardiac excitability secondary to reduction of sodium current may be a significant contributor to reduced contractility in a rat model of sepsis. Crit Care 18(2):R54. doi:10.1186/cc13800
Lancaster MK, Cook SJ (1997) The effects of levosimendan on [Ca2 +]I in guinea-pig isolated ventricular myocytes. Eur J Pharmacol 339(1):97–100. doi:10.1016/S0014-2999(97)01362-9
Landesberg G, Gilon D, Meroz Y, Georgieva M, Levin PD, Goodman S, Avidan A, Beeri R, Weissman C, Jaffe AS, Sprung CL (2012) Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J 33:895–903. doi:10.1093/eurheartj/ehr351
Li C, YanG YC, Hwang GY, Kao LS, Lin CY (2014) Inhibition of reverse-mode sodium-calcium exchanger activity and apoptosis by levosimendan in human cardiomyocyte progenitor cell-derived cardiomyocytes after anoxia and reoxygenation. PLoS One 9(2):e85909. doi:10.1371/journal.pone.0085909
Magi S, Nasti AA, Gratteri S, Castaldo P, Bompadre S, Amoroso S, Lariccia V (2015) Gram-negative endotoxin lipopolysaccharide induces cardiac hypertrophy: detrimental role of Na(+)-Ca(2 +)-exchanger. Eur J Pharmacol 746:31–40. doi:10.1016/j.ejphar.2014.10.054
Morelli A, De Castro S, Teboul JL, Singer M, Ronco M, Conti G, De Luca L, Di Angelantonia E, Orecchioni A, Pandian NG, Pietropaoli P (2005) Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31:638–644. doi:10.1007/s00134-005-2619-z
Negretti N, O’Neill SC, Eisner DA (1993) The relative contributions of different intracellular and sarcolemmal systems to relaxation in rat ventricular myocytes. Cardiovasc Res 27:1826–1830. doi:10.1093/cvr/27.10.1826
Orme RM, Perkins GD, McAuley DF, Liu KD, Mason AJ, Morelli A, Singer M, Ashby D, Gordon AC (2014) An efficacy and mechanism evaluation study of levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial. Trials 15:199. doi:10.1186/1745-6215-15-199
Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GO, Levy FO, Skomedal T, Osnes JB, Qvigstad E (2014) Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart. Br J Pharmacol 171(23):5169–5181. doi:10.1111/bph.12647
Orstavik O, Manfra O, Andressen KW, Andersen GO, Skomedal T, Osnes JB, Levy FO, Krobert KA (2015) The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium. PLoS One 10(3):e0115547. doi:10.1371/journal.pone.0115547
Ren J, Ren BH, Sharma AC (2002) Sepsis-induced depressed contractile function of isolated ventricular myocytes is due to altered calcium transient properties. Shock 18(3):285–288. doi:10.1097/00024382-200209000-00014
Rozenberg S, Besse S, Brisson H, Jozefowicz E, Kandoussi A, Mebazaa A, Riou B, Vallet B, Tavernier B (2006) Endotoxin-induced myocardial dysfunction in senescent rats. Crit Care 10(4):R124. doi:10.1186/cc5033
Rudiger A, Singer M (2013) The heart in sepsis: from basic mechanisms to clinical management. Curr Vasc Pharmacol 11(2):187–195. doi:10.2174/1570161111311020008
Svensson C, Morano I, Arner A (1997) In vitro motility assay of atrial and ventricular myosin from pig. J Cell Biochem 67(2):241–247. doi:10.1002/(SICI)1097-4644(19971101)67:2<241:AID-JCB9>3.0.CO;2-X
Szalay L, Kaszaki J, Nagy S, Boros M (1998) The role of endothelin-1 in circulatory changes during hypodynamic sepsis in the rat. Shock 10(2):123–128
Tavernier B, Garrigue D, Boulle C, Vallet B, Adnet P (1998) Myofilament calcium sensitivity is decreased in skinned cardiac fibres of endotoxin-treated rabbits. Cardiovasc Res 38(2):472–479. doi:10.1016/S0008-6363(98)00028-5
Van de Sandt AM, Windler R, Gödecke A, Ohlig J, Zander S, Reinartz M, Graf J, van Faassen EE, Rassaf T, Schrader J, Kelm M, Merx MW (2013) Endothelial NOS (NOS3) impairs myocardial function in developing sepsis. Baris Res Cardiol 108:330. doi:10.1007/s00395-013-0330-8
Vieillard-Baron A (2011) Septic cardiomyopathy. Ann Intensive Care 1(1):6. doi:10.1186/2110-5820-1-6
Wagner S, Knipp S, Weber C, Hein S, Schinkel S, Walther A, Bekeredjian R, Müller OJ, Friedrich O (2012) The heart in Duchenne muscular dystrophy: early detection of contractile performance alteration. J Cell Mol Med 16(12):3028–3036. doi:10.1111/j.1582-4934.2012.01630.x
Werdan K, Müller U, Reithmann C, Pfeifer A, Hallström S, Koidl B, Schlag G (1991) Mechanisms in acute septic cardiomyopathy: evidence from isolated myocytes. Basic Res Cardiol 86(5):411–421. doi:10.1007/BF02190709
Wu LL, Liu MS (1992) Heart sarcolemmal Ca2 + transport in endotoxin shock: I. impairment of ATP-dependent Ca2 + transport. Mol Cell Biochem 112(2):125–133. doi:10.1007/BF00227569
Wu LL, Tang C, Liu MS (2001) Altered phosphorylation and calcium sensitivity of cardiac myofibrillar proteins during sepsis. Am J Physiol Regul Integr Comp Physiol 281(2):R408–R416
Yu X, Jia B, Wang F, Lv X, Peng X, Wang Y, Li H, Wang Y, Lu D, Wang H (2014) α1 adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway. J Cell Mol Med 18(2):263–273. doi:10.1111/jcmm.12184
Zausig YA, Geilfus D, Missler G, Sinenr B, Graf BM, Zink W (2010) Direct cardiac effects of dobutamine, dopamine, epinephrine, and levosimendan in isolated septic rat hearts. Shock 34(3):269–274. doi:10.1097/SHK.0b013e3181cd877b
Zhang XH, Li GR, Bourreau JP (2007) The effect of adrenomedullin on the L-type calcium current in myocytes from septic shock rats: signaling pathway. Am J Physiol Heart Circ Physiol 293(5):H2888–H2893. doi:10.1152/ajpheart.00312.2007
Zhu X, Bernecker OY, Manohar NS, Haijar RJ, Hellman J, Ichinose F, Valdiva HH, Schmidt U (2005) Increased leakage of sarcoplasmic reticulum Ca2 + contributes to abnormal myocyte Ca2 + handling and shortening in sepsis. Crit Care Med 33(3):598–604. doi:10.1097/01.CCM.0000152223.27176.A6
Acknowledgments
This work was partly supported by the ELAN Fonds of the Erlangen Medical Faculty (13-02-25-1). The authors acknowledge excellent technical help from R Galmbacher and C Weber for catheter experiments and in vitro motility assays.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wagner, S., Schürmann, S., Hein, S. et al. Septic cardiomyopathy in rat LPS-induced endotoxemia: relative contribution of cellular diastolic Ca2+ removal pathways, myofibrillar biomechanics properties and action of the cardiotonic drug levosimendan. Basic Res Cardiol 110, 50 (2015). https://doi.org/10.1007/s00395-015-0507-4
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00395-015-0507-4